Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Genetic Predisposition to Type 2 Diabetes and Risk of Subclinical Atherosclerosis and Cardiovascular Diseases Among 160,000 Chinese Adults

Gan W. et al, (2019), Diabetes, 68, 2155 - 2164

Variants in the fetal genome near pro-inflammatory cytokine genes on 2q13 associate with gestational duration.

Liu X. et al, (2019), Nature communications, 10

Exome-Derived Adiponectin-Associated Variants Implicate Obesity and Lipid Biology

Spracklen CN. et al, (2019), The American Journal of Human Genetics, 105, 670 - 671

ZRANB3 is an African-specific type 2 diabetes locus associated with beta-cell mass and insulin response.

Adeyemo AA. et al, (2019), Nature communications, 10

Genome-wide association study of type 2 diabetes in Africa.

Chen J. et al, (2019), Diabetologia, 62, 1204 - 1211

Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls.

Flannick J. et al, (2019), Nature, 570, 71 - 76

Variation in the Plasma Membrane Monoamine Transporter (PMAT) (Encoded by SLC29A4) and Organic Cation Transporter 1 (OCT1) (Encoded by SLC22A1) and Gastrointestinal Intolerance to Metformin in Type 2 Diabetes: An IMI DIRECT Study.

Dawed AY. et al, (2019), Diabetes care, 42, 1027 - 1033

Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors.

Warrington NM. et al, (2019), Nature genetics, 51, 804 - 814

Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases.

Sanna S. et al, (2019), Nature genetics, 51, 600 - 605

Developing a network view of type 2 diabetes risk pathways through integration of genetic, genomic and functional data.

Fernández-Tajes J. et al, (2019), Genome medicine, 11

The Early Growth Genetics (EGG) and EArly Genetics and Lifecourse Epidemiology (EAGLE) consortia: design, results and future prospects.

Middeldorp CM. et al, (2019), European journal of epidemiology, 34, 279 - 300

Dissecting features of epigenetic variants underlying cardiometabolic risk using full-resolution epigenome profiling in regulatory elements.

Allum F. et al, (2019), Nature communications, 10

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.

Rhodes CJ. et al, (2019), The Lancet. Respiratory medicine, 7, 227 - 238

Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution

Justice AE. et al, (2019), Nature Genetics, 51, 452 - 469

The Genetic Basis of Metabolic Disease.

Barroso I. and McCarthy MI., (2019), Cell, 177, 146 - 161

A novel rare CUBN variant and three additional genes identified in Europeans with and without diabetes: results from an exome-wide association study of albuminuria.

Ahluwalia TS. et al, (2019), Diabetologia, 62, 292 - 305

Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control

Pollack S. et al, (2019), Diabetes, 68, 441 - 456

Plasma Fucosylated Glycans and C-Reactive Protein as Biomarkers of HNF1A-MODY in Young Adult–Onset Nonautoimmune Diabetes

Juszczak A. et al, (2019), Diabetes Care, 42, 17 - 26

Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.

Day F. et al, (2018), PLoS genetics, 14

Erratum: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls

Flannick J. et al, (2018), Scientific Data, 5

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?